Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| TCR2 THERAPEUTICS INC. | 0 | reported | 01 Jun 2023 | tx 6+280,854−280,854 |
| Trillium Therapeutics Inc. | 0 | reported | 17 Nov 2021 | tx 2−180,075 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 01 Jun 2023 | OTHER | TCR2 THERAPEUTICS INC. | 191,102 | 0.00 USD | deriv |
| 01 Jun 2023 | OTHER | TCR2 THERAPEUTICS INC. | 76,930 | 0.00 USD | deriv |
| 01 Jun 2023 | OTHER | TCR2 THERAPEUTICS INC. | 12,822 | 0.00 USD | deriv |
| 15 Dec 2022 | GRANT_AWARD | TCR2 THERAPEUTICS INC. | 12,822 | 0.00 USD | deriv |
| 15 Dec 2022 | GRANT_AWARD | TCR2 THERAPEUTICS INC. | 76,930 | 0.00 USD | deriv |
| 10 Jan 2022 | GRANT_AWARD | TCR2 THERAPEUTICS INC. | 191,102 | 0.00 USD | deriv |
| 17 Nov 2021 | OTHER | Trillium Therapeutics Inc. | 75 | — | |
| 17 Nov 2021 | OTHER | Trillium Therapeutics Inc. | 180,000 | 0.00 USD | deriv |